drug protocol number

CA0731003

drug sponsor

Celgene Corporation / Balsam Clinical Research

drug study

Golcadomide / Rituximab

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase